| # | Drug | Count |
|---|---|---|
| 0 | TACROLIMUS | 6 |
| 1 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 6 |
| 2 | TACROLIMUS OINTMENT 0.1% | 6 |
| 3 | ABACAVIR | 5 |
| 4 | ABACAVIR SULFATE | 5 |
| 5 | LAMIVUDINE | 5 |
| 6 | LAMIVUDINE ORAL | 5 |
| 7 | PREDNISONE | 5 |
| 8 | INSULIN | 3 |
| 9 | NEVIRAPINE | 3 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | DORAVIRINE | 1 | 0.0013 |
| 1 | ABACAVIR SULFATE | 5 | 0.0005 |
| 2 | NEVIRAPINE | 3 | 0.0003 |
| 3 | LAMIVUDINE | 5 | 0.0002 |
| 4 | ABACAVIR SULFATE, DOLUTEGRAVIR SODIUM, LAMIVUDINE | 1 | 0.0002 |
| 5 | EFAVIRENZ | 1 | 0.0001 |
| 6 | CICLESONIDE | 1 | 0.0001 |
| 7 | LINEZOLID | 2 | 0.0001 |
| 8 | EVEROLIMUS TABLETS | 1 | 0.0001 |
| 9 | TACROLIMUS OINTMENT 0.1% | 6 | 0.0000 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 5 | 0.0002 |
| 1 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 6 | 0.0001 |
| 2 | Oxazolidinone Antibacterial [EPC] | 2 | 0.0001 |
| 3 | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 7 | 0.0001 |
| 4 | Nucleoside Analog Antiviral [EPC] | 2 | 0.0000 |
| 5 | Insulin Analog [EPC] | 3 | 0.0000 |
| 6 | Corticosteroid [EPC] | 6 | 0.0000 |
| 7 | Progestin [EPC] | 1 | 0.0000 |
| 8 | Kinase Inhibitor [EPC] | 1 | 0.0000 |